NLRP1-Mediated Antidepressant Effect of Ketamine in Chronic Unpredictable Mild Stress Model in Rats

키워드

참고문헌 (48)

1. Iwata M, "The inflammasome : pathways linking psychological stress, depression, and systemic illnesses", Brain Behav Immun, 31, pp.105~114 (2013)
2. Palazidou E, "The neurobiology of depression", Br Med Bull, 101, pp.127~145 (2012)
3. Sanacora G, "Towards a glutamate hypothesis of depression : an emerging frontier of neuropsychopharmacology for mood disorders", Neuropharmacology, 62, pp.63~77 (2012)
4. Browne CA, "Antidepressant effects of ketamine : mechanisms underlying fast-acting novel antidepressants", Front Pharmacol, 4, pp.161~ (2013)
5. Zarate C, "New paradigms for treatment-resistant depression", Ann N Y Acad Sci, 1292, pp.21~31 (2013)
6. Li M, "Inflammatory biomarkers in depression : an opportunity for novel therapeutic interventions", Curr Psychiatry Rep, 13, pp.316~320 (2011)
7. Kavalali ET, "How does ketamine elicit a rapid antidepressant response", Curr Opin Pharmacol, 20, pp.35~39 (2015)
8. Sild M, "Major depressive disorder and anxiety disorders from the glial perspective : Etiological mechanisms, intervention and monitoring", Neurosci Biobehav Rev, 83, pp.474~488 (2017)
9. Wang Q, "An astroglial basis of major depressive disorder? An overview", Glia, 65, pp.1227~1250 (2017)
10. Janks L, "A central role for P2X7 receptors in human microglia", J Neuroinflammation, 15, pp.325~ (2018)
11. in mice by inhibiting TLR-4, "NF-κB pathway", Biochem Biophys Res Commun, 507, pp.43~50 (2018)
12. Bhattacharya A, "Emerging role of the P2X7-NLRP3-IL1βpathway in mood disorders", Psychoneuroendocrinology, 98, pp.95~100 (2018)
13. Alyu F, "Inflammatory aspects of epileptogenesis : contribution of molecular inflammatory mechanisms", Acta Neuropsychiatr, 29, pp.1~16 (2017)
14. Feyza Aricioglu, "Antidepressant-like Effects Induced by Chronic Blockade of the Purinergic 2X7 Receptor through Inhibition of Non-like Receptor Protein 1 Inflammasome in Chronic Unpredictable Mild Stress Model of Depression in Rats", Clinical Psychopharmacology and Neuroscience, 17(2), pp.261~272 (2019), 대한정신약물학회[DOI]
15. Willner P, "Chronic mild stress-induced anhedonia : a realistic animal model of depression", Neurosci Biobehav Rev, 16, pp.525~534 (1992)
16. Sarkisova KY, "Spikewave discharges are necessary for the expression of behavioral depression-like symptoms", Epilepsia, 51, pp.146~160 (2010)
17. Porsolt RD, "Depression : a new animal model sensitive to antidepressant treatments", Nature, 266, pp.730~732 (1977)
18. Gerhard DM, "Emerging treatment mechanisms for depression : focus on glutamate and synaptic plasticity", Drug Discov Today, 21, pp.454~464 (2016)
19. Hill MN, "Neurobiology of chronic mild stress : parallels to major depression", Neurosci Biobehav Rev, 36, pp.2085~2117 (2012)
20. Garcia LS, "Ketamine treatment reverses behavioral and physiological alterations induced by chronic mild stress in rats", Prog Neuropsychopharmacol Biol Psychiatry, 33, pp.450~455 (2009)
21. Tizabi Y, "Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA", NMDA receptor density ratio in female Wistar-Kyoto rats, 2012, pp.213, 72~80
22. Li N, "Glutamate Nmethyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure", Biol Psychiatry, 69, pp.754~761 (2011)
23. Yap JKY, "The Role of Neuronal NLRP1 Inflammasome in Alzheimer’s Disease : Bringing Neurons into the Neuroinflammation Game", Mol Neurobiol, 56, pp.7741~7753 (2019)
24. Kaushal V, "Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation", Cell Death Differ, 22, pp.1676~1686 (2015)
25. Inserra A, "Neuroimmunomodulation in major depressive disorder : focus on caspase 1, inducible nitric oxide synthase, and interferon-gamma", Mol Neurobiol, 56, pp.4288~4305 (2019)
26. Dick MS, "ASC filament formation serves as a signal amplification mechanism for inflammasomes", Nat Commun, 7, pp.11929~ (2016)
27. Kim KN, "5-Bromo-2-hydroxy-4-methyl-benzaldehyde inhibited LPS-induced production of pro-inflammatory mediators through the inactivation of ERK, p38, and NF-κB pathways in RAW 264. 7 macrophages", Chem Biol Interact, 258, pp.108~114 (2016)
28. Wu Y, "Ketamine inhibits lipopolysaccharide-induced astrocytes activation by suppressing TLR4", NF-ĸB pathway, 2012, pp.30, 609~617
29. Welters ID, "Ketamine inhibits transcription factors activator protein 1and nuclear factor-kappaB, interleukin-8 production, as well as CD11b and CD16 expression : studies in human leukocytes and leukocytic cell lines", Anesth Analg, 110, pp.934~941 (2010)
30. Yu M, "Ketamine suppresses intestinal TLR4 expression and NF-kappaB activity in lipopolysaccharide-treated rats", Croat Med J, 47, pp.825~831 (2006)
31. Sakai T, "Ketamine suppresses endotoxin-induced NF-kappaB expression", Can J Anaesth, 47, pp.1019~1024 (2000)
32. Yu M, "Effects of ketamine on levels of cytokines, NF-kappaB and TLRs in rat intestine during CLP-induced sepsis", Int Immunopharmacol, 7, pp.1076~1082 (2007)
33. Sun J, "Ketamine inhibits LPS-induced calcium elevation and NF-kappa B activation in monocytes", Inflamm Res, 53, pp.304~308 (2004)
34. "2017", 234
35. Liu W, "The role of nitric oxide in the antidepressant actions of 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside in insulin-resistant mice", Psychosom Med, 78, pp.102~112 (2016)
36. Deng X, "Irisin alleviates advanced glycation end products-induced inflammation and endothelial dysfunction via inhibiting ROS-NLRP3 inflammasome signaling", Inflammation, 41, pp.260~275 (2018)
37. Tanaka T, "General anesthetics inhibit LPS-induced IL-1β expression in glial cells", PLoS One, 8, pp.e82930~ (2013)
38. Chen RM, "Ketamine reduces nitric oxide biosynthesis in human umbilical vein endothelial cells by down-regulating endothelial nitric oxide synthase expression and intracellular calcium levels", Crit Care Med, 33, pp.1044~1049 (2005)
39. Weckmann K, "Ketamine’s Effects on the Glutamatergic and GABAergic Systems : A Proteomics and Metabolomics Study in Mice", Mol Neuropsychiatry, 5, pp.42~51 (2019)
40. Tan S, "Ketamine alleviates depressivelike behaviors via down-regulating inflammatory cytokines induced by chronic restraint stress in mice", Biol Pharm Bull, 40, pp.1260~1267 (2017)
41. Taniguchi T, "Ketamine inhibits endotoxininduced shock in rats", Anesthesiology, 95, pp.928~932 (2001)
42. Helmer KS, "Effects of ketamine", xylazine on expression of tumor necrosis factor-alpha, inducible nitric oxide synthase, and cyclo-oxygenase-2 in rat gastric mucosa during endotoxemia, 2003, pp.20, 63~69
43. "2016", 233
44. Kreisel T, "Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis", Mol Psychiatry, 19, pp.699~709 (2014)
45. Zhu X, "Ketamine-mediated alleviation of electroconvulsive shock-induced memory impairment is associated with the regulation of neuroinflammation and soluble amyloid-beta peptide in depressive-like rats", Neurosci Lett, 599, pp.32~37 (2015)
46. Fehlings MG, "Immunoglobulin G : a potential treatment to attenuate neuroinflammation following spinal cord injury", J Clin Immunol, 30(Suppl 1), pp.S109~S112 (2010)
47. Zhang GF, "Repeated ketamine administration redeems the time lag for citalopram’s antidepressant-like effects", Eur Psychiatry, 30, pp.504~510 (2015)
48. Duman RS, "Signaling pathways underlying the pathophysiology and treatment of depression : novel mechanisms for rapid-acting agents", Trends Neurosci, 35, pp.47~56 (2012)

관련 논문AI추천